Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01815619 · ClinicalTrials.gov registry record · NA
Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT01815619 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 62 participants.
The verdict
NCT01815619, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study will test two different methods for processing biopsy specimens taken from the bile duct. Patient;s who are asked to participate int his study have a stricture in the bile duct that needs a single operator cholangioscopy-guided biopsies during endoscopic retrograde cholangiopancreatography (ERCP) so that a diagnosis can be made. Standard of care includes performing single operator cholangioscopy-guided biopsies in the bile duct and sending the tissue to the lab for testing to make a diagnosis. Using this method the investigators can establish a diagnosis only about 50% of the time. The investigators believe that if a cytopathologist is available in the endoscopy suite during the procedure to evaluate the biopsy specimens onsite, the investigators can improve the diagnostic accuracy. The purpose of this study is to compare two methods for processing biopsies obtained from the bile duct (Onsite vs. Offsite).
Interventions
- OTHER on-site specimen evaluation
- OTHER off-site specimen evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-02 |
| Est. Completion | 2020-08-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01815619
The ClinicalTrials.gov registry entry for NCT01815619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which on-site specimen evaluation is the first listed.
NCT01815619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01815619 about?
NCT01815619 is a clinical study titled "Comparison of On-Site Versus Off-Site Evaluation of Cholangioscopy-Guided Biopsies of the Bile Duct". This study will test two different methods for processing biopsy specimens taken from the bile duct. Patient;s who are asked to participate int his study have a stricture in the bile duct that needs a single operator cholangioscopy-guided biopsies during endoscopic retrograde cholangiopancreatograph...
What is the current status of trial NCT01815619?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2013-02. Estimated completion is 2020-08-25.
What interventions are being tested in trial NCT01815619?
The interventions under investigation include: on-site specimen evaluation (OTHER), off-site specimen evaluation (OTHER).
Who is sponsoring clinical trial NCT01815619?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.